首页> 外文期刊>Scientific reports. >Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway
【24h】

Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway

机译:硫氧还蛋白相互作用蛋白(TXNIP)通过mTOR信号通路调节糖尿病肾病的肾小管自噬和线粒体

获取原文
           

摘要

Hyperglycemia upregulates thioredoxin interacting protein (TXNIP) expression, which in turn induces ROS production, inflammatory and fibrotic responses in the diabetic kidney. Dysregulation of autophagy contributes to the development of diabetic nephropathy. However, the interaction of TXNIP with autophagy/mitophagy in diabetic nephropathy is unknown. In this study, streptozotocin-induced diabetic rats were given TXNIP DNAzyme or scrambled DNAzyme for 12 weeks respectively. Fibrotic markers, mitochondrial function and mitochondrial reactive oxygen species (mtROS) were assessed in kidneys. Tubular autophagy and mitophagy were determined in kidneys from both human and rats with diabetic nephropathy. TXNIP and autophagic signaling molecules were examined. TXNIP DNAzyme dramatically attenuated extracellular matrix deposition in the diabetic kidneys compared to the control DNAzyme. Accumulation of autophagosomes and reduced autophagic clearance were shown in tubular cells of human diabetic compared to non-diabetic kidneys, which was reversed by TXNIP DNAzyme. High glucose induced mitochondrial dysfunction and mtROS production, and inhibited mitophagy in proximal tubular cells, which was reversed by TXNIP siRNA. TXNIP inhibition suppressed diabetes-induced BNIP3 expression and activation of the mTOR signaling pathway. Collectively, hyperglycemia-induced TXNIP contributes to the dysregulation of tubular autophagy and mitophagy in diabetic nephropathy through activation of the mTOR signaling pathway.
机译:高血糖会上调硫氧还蛋白相互作用蛋白(TXNIP)的表达,进而诱导糖尿病肾中ROS的产生,炎症和纤维化反应。自噬的失调有助于糖尿病性肾病的发展。然而,糖尿病肾病中TXNIP与自噬/有丝分裂的相互作用尚不清楚。在这项研究中,链脲佐菌素诱导的糖尿病大鼠分别给予TXNIP DNAzyme或加扰的DNAzyme,持续12周。在肾脏中评估了纤维化标记物,线粒体功能和线粒体活性氧(mtROS)。在患有糖尿病肾病的人和大鼠的肾脏中确定了管状自噬和线粒体吞噬。检查了TXNIP和自噬信号分子。与对照DNAzyme相比,TXNIP DNAzyme大大减轻了糖尿病肾脏中细胞外基质的沉积。与非糖尿病肾相比,在糖尿病人的肾小管细胞中显示了自噬体的积累和自噬清除率的降低,这被TXNIP DNAzyme逆转。高糖诱导线粒体功能障碍和mtROS产生,并抑制近端肾小管细胞的线粒体吞噬,这被TXNIP siRNA逆转。 TXNIP抑制抑制糖尿病诱导的BNIP3表达和mTOR信号通路的激活。集体地,高血糖诱导的TXNIP通过激活mTOR信号通路,导致糖尿病肾病中肾小管自噬和线粒体吞噬失调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号